| INDRAYANI BIOTECH  Back to All Ratios | 
INDRAYANI BIOTECH Last 5 Year Core EBITDA Growth History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Core EBITDA Growth(%) | 14.11 | 211.29 | 249.66 | -257.33 | 320.67 | 
What is the latest Core EBITDA Growth ratio of INDRAYANI BIOTECH ?
| Year | Core EBITDA Growth | 
|---|---|
| Mar2024 | 14.11 | 
| Mar2023 | 211.29 | 
| Mar2022 | 249.66 | 
| Mar2021 | -257.33 | 
| Mar2020 | 320.67 | 
How is Core EBITDA Growth of INDRAYANI BIOTECH Trending?
| Years | Core EBITDA Growth | % Change | |
|---|---|---|---|
| Mar2024 | 14.11 | -93.32 | |
| Mar2023 | 211.29 | -15.37 | |
| Mar2022 | 249.66 | Positive | |
| Mar2021 | -257.33 | Negative | |
| Mar2020 | 320.67 | - | |
Other Financial Ratios of INDRAYANI BIOTECH
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap | 
Compare Core EBITDA Growth ratio of peers of INDRAYANI BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDRAYANI BIOTECH | ₹64.2 Cr | -6.5% | 11.6% | -61% | Stock Analytics | |
| No other companies found in this Industry | ||||||
INDRAYANI BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| INDRAYANI BIOTECH | -6.5% | 11.6% | -61% | 
| SENSEX | -0.2% | 5% | 5.4% | 
You may also like the below Video Courses
 
                     
                                     
                                     
                                    